Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$198,931,653
+$5,397,261 QoQ
Shares Held
783,288
-1.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#204
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. JNJ ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $198,931,653 | 783,288 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $193,534,392 | 791,746 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $130,277,715 | 629,513 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $113,669,135 | 613,036 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $92,972,967 | 608,661 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $100,684,780 | 607,120 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $77,169,232 | 533,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $87,306,097 | 538,727 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,266,394 | 549,168 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $88,010,746 | 556,361 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $103,223,007 | 658,562 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $104,694,838 | 672,198 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $112,508,413 | 679,727 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $101,154,240 | 652,608 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $108,858,442 | 616,238 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $98,071,215 | 600,338 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $84,717,535 | 477,255 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $77,878,761 | 439,422 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $79,253,651 | 463,282 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $73,745,422 | 456,628 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $64,875,435 | 393,805 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $62,703,962 | 381,527 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $55,701,346 | 353,929 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,172,235 | 330,281 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $48,714,091 | 346,399 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $43,177,568 | 329,273 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||